Overall, data from distinct available genomic projects in cBioPortal showed a low prevalence of structural alterations in DDIT4. In malignant breast tumors DDIT4 mutations had frequencies ranging: 0.4–1.5% in primary breast tumors (mainly amplifications). This evidence concerns the gene DDIT4 and breast cancer.